93 related articles for article (PubMed ID: 8540319)
21. Similarities and differences in the biogenesis, processing and lysosomal targeting between zebrafish and human pro-Cathepsin D: functional implications.
Follo C; Ozzano M; Montalenti C; Ekkapongpisit M; Isidoro C
Int J Biochem Cell Biol; 2013 Feb; 45(2):273-82. PubMed ID: 23107604
[TBL] [Abstract][Full Text] [Related]
22. Identification of five molecular forms of cathepsin D in bovine milk.
Larsen LB; Petersen TE
Adv Exp Med Biol; 1995; 362():279-83. PubMed ID: 8540328
[No Abstract] [Full Text] [Related]
23. Purification and partial characterization of cathepsin D from porcine (Sus scrofa) liver using affinity chromatography.
Canduri F; Ward RJ; de Azevedo Júnior WF; Gomes RA; Arni RK
Biochem Mol Biol Int; 1998 Jul; 45(4):797-803. PubMed ID: 9713704
[TBL] [Abstract][Full Text] [Related]
24. Human procathepsin D: three-dimensional model and isolation.
Koelsch G; Metcalf P; Vetvicka V; Fusek M
Adv Exp Med Biol; 1995; 362():273-8. PubMed ID: 8540327
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of plasmepsin II. A comparison with human aspartic proteases.
Silva AM; Lee AY; Erickson JW; Goldberg DE
Adv Exp Med Biol; 1998; 436():363-73. PubMed ID: 9561243
[No Abstract] [Full Text] [Related]
26. Non-mammalian vertebrate pepsinogens and pepsins: isolation and characterization.
Takahashi K; Tanji M; Yakabe E; Hirasawa A; Athauda SB; Kageyama T
Adv Exp Med Biol; 1995; 362():53-65. PubMed ID: 8540368
[No Abstract] [Full Text] [Related]
27. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.
Baldwin ET; Bhat TN; Gulnik S; Hosur MV; Sowder RC; Cachau RE; Collins J; Silva AM; Erickson JW
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6796-800. PubMed ID: 8393577
[TBL] [Abstract][Full Text] [Related]
28. Amino acid sequence of porcine spleen cathepsin D light chain.
Takahashi T; Tang J
J Biol Chem; 1983 May; 258(10):6435-43. PubMed ID: 6406481
[TBL] [Abstract][Full Text] [Related]
29. Human cathepsin D.
Minarowska A; Gacko M; Karwowska A; Minarowski Ł
Folia Histochem Cytobiol; 2008; 46(1):23-38. PubMed ID: 18296260
[TBL] [Abstract][Full Text] [Related]
30. Intracellular targeting of lysosomal cathepsin D in COS cells.
Takeshima H; Sakaguchi M; Mihara K; Murakami K; Omura T
J Biochem; 1995 Nov; 118(5):981-8. PubMed ID: 8749316
[TBL] [Abstract][Full Text] [Related]
31. A new way of looking at aspartic proteinase structures: a comparison of pepsin structure to other aspartic proteinases in the near active site region.
Andreeva NS; Bochkarev A; Pechik I
Adv Exp Med Biol; 1995; 362():19-32. PubMed ID: 8540318
[No Abstract] [Full Text] [Related]
32. Site-directed mutagenesis of a disulfide bridge in cathepsin D: expression, activation, purification, and characterization.
Beyer BM; Dunn BM
Adv Exp Med Biol; 1995; 362():285-7. PubMed ID: 8540329
[No Abstract] [Full Text] [Related]
33. Mechanisms of a conversion from membrane associated lysosomal acid phosphatase to content forms.
Himeno M; Nakamura K; Tanaka Y; Yamada H; Imoto T; Kato K
Biochem Biophys Res Commun; 1991 Nov; 180(3):1483-9. PubMed ID: 1953791
[TBL] [Abstract][Full Text] [Related]
34. Amino acid sequence of porcine spleen cathepsin D.
Shewale JG; Tang J
Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3703-7. PubMed ID: 6587385
[TBL] [Abstract][Full Text] [Related]
35. Hydroxysteroid dehydrogenases. New drug targets of the aldo-keto reductase superfamily.
Penning TM
Adv Exp Med Biol; 1997; 414():475-90. PubMed ID: 9059653
[No Abstract] [Full Text] [Related]
36. Folding, activity and targeting of mutated human cathepsin D that cannot be processed into the double-chain form.
Follo C; Castino R; Nicotra G; Trincheri NF; Isidoro C
Int J Biochem Cell Biol; 2007; 39(3):638-49. PubMed ID: 17188016
[TBL] [Abstract][Full Text] [Related]
37. Exploration of subsite binding specificity of human cathepsin D through kinetics and rule-based molecular modeling.
Scarborough PE; Guruprasad K; Topham C; Richo GR; Conner GE; Blundell TL; Dunn BM
Protein Sci; 1993 Feb; 2(2):264-76. PubMed ID: 8443603
[TBL] [Abstract][Full Text] [Related]
38. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
[TBL] [Abstract][Full Text] [Related]
39. Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts.
Glickman JN; Kornfeld S
J Cell Biol; 1993 Oct; 123(1):99-108. PubMed ID: 8408210
[TBL] [Abstract][Full Text] [Related]
40. Structure and proposed amino-acid sequence of a pepsin from atlantic cod (Gadus morhua).
Karlsen S; Hough E; Olsen RL
Acta Crystallogr D Biol Crystallogr; 1998 Jan; 54(Pt 1):32-46. PubMed ID: 9761815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
